• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

clinical trial data

Completing steps towards success checkmark on cubes symbolizing progress
Biotech

Nektar eczema asset 'checked all of the boxes' in phase 2

The results set rezpeg up to become “a preferred second-line therapy” in atopic dermatitis.
Darren Incorvaia Feb 10, 2026 10:55am
Completing steps towards success checkmark on cubes symbolizing progress

Roche unveils data behind BTK inhibitor's phase 3 MS win

Feb 9, 2026 7:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Racing BMS and J&J, Bayer ties asundexian to 26% stroke decrease

Feb 5, 2026 12:15pm
Dark and dramatic sky with sunlight

Skye links CB1-Wegovy combo to 22.3% weight loss after a year

Feb 2, 2026 8:08am
Completing steps towards success checkmark on cubes symbolizing progress

Merck, Moderna sustain 49% melanoma risk reduction at 5 years

Jan 20, 2026 8:50am
Lightbulb with an image of a brain inside

Bright Minds anti-seizure candidate shines in phase 2 win

Jan 6, 2026 10:38am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings